Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 3Plasma cell 1Myeloid 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 21Neoplasms, Plasma Cell 11Lymphoma, Non-Hodgkin 11Lymphoma 11Leukemia, Lymphocytic, Chronic, B-Cell 10Hodgkin Disease 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia 8Burkitt Lymphoma 8Myelodysplastic Syndromes 7Lymphoma, Mantle-Cell 7Leukemia, Myeloid, Acute 7Leukemia, Myeloid, Accelerated Phase 5Waldenstrom Macroglobulinemia 4Recurrence 4Leukemia, Myelomonocytic, Chronic 4Leukemia, Myeloid, Chronic-Phase 4Congenital Abnormalities 4Blast Crisis 4Anemia, Refractory, with Excess of Blasts 4Primary Myelofibrosis 3Myeloproliferative Disorders 3Myelodysplastic-Myeloproliferative Diseases 3Dendritic Cell Sarcoma, Interdigitating 3Pdgfra-Associated Chronic Eosinophilic Leukemia 2Leukemia, Plasma Cell 2

Interventions

Melphalan 2Filgrastim 2Fibroblast Growth Factor 7 2Cyclophosphamide 2Amifostine 2sargramostim 1Sirolimus 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Ifosfamide 1Etoposide 1Epoetin Alfa 1Deoxycytidine 1Cytarabine 1Carboplatin 1Antilymphocyte Serum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Drug-Related Side Effects and Adverse Reactions × Cytarabine × Plasma cell × Clear all
NCT00002818 2015-12-14

High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic Malignancies

Virginia Commonwealth University

Phase 1 Completed
15 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡